Verus Investment Partners recently announced that it has sold VanDeMark Chemical Inc. for an undisclosed value.

“Since we acquired VanDeMark in 2012, it has increased its revenue, entered new markets and extended the range of applications for its portfolio of chemical compounds based on phosgenation chemistry,” said Christopher P. Fuller, managing partner. “The company also successfully grew by acquisition with its transformative purchase of Framochem Kft in Hungary in 2014. We now wish VanDeMark continued success.”

Under the terms of the agreement, VanDeMark’s chief executive officer Mike Kucharski, who joined the company in 1983, will continue as CEO, as will the rest of the management team.

For more information, visit www.veruspartners.com or www.vandemark.com.